TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
This Quarter Return
+1.62%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.38B
AUM Growth
+$33.2M
Cap. Flow
-$39.1M
Cap. Flow %
-1.64%
Top 10 Hldgs %
40.59%
Holding
153
New
10
Increased
26
Reduced
20
Closed
10

Top Buys

1
ABT icon
Abbott
ABT
$37.5M
2
COR icon
Cencora
COR
$29.9M
3
CVS icon
CVS Health
CVS
$21.4M
4
NBIX icon
Neurocrine Biosciences
NBIX
$20.7M
5
GILD icon
Gilead Sciences
GILD
$15.1M

Top Sells

1
CELG
Celgene Corp
CELG
$34.4M
2
MDVN
MEDIVATION, INC.
MDVN
$24.8M
3
NVO icon
Novo Nordisk
NVO
$16M
4
VTR icon
Ventas
VTR
$15.8M
5
DOC
PHYSICIANS REALTY TRUST
DOC
$14.7M

Sector Composition

1 Healthcare 88.83%
2 Real Estate 2.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NVAX icon
101
Novavax
NVAX
$1.2B
$2.6M 0.11%
17,900
– –
FWP
102
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$2.48M 0.1%
19,507
– –
ADAP
103
Adaptimmune Therapeutics
ADAP
$13.9M
$2.42M 0.1%
296,934
– –
ORKA
104
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
$2.35M 0.1%
3,756
– –
CCP
105
DELISTED
Care Capital Properties, Inc.
CCP
$2.21M 0.09%
84,316
– –
MDRX
106
DELISTED
Veradigm Inc. Common Stock
MDRX
$2.21M 0.09%
173,600
– –
DBVT
107
DBV Technologies
DBVT
$249M
$2.14M 0.09%
6,560
– –
BLUE
108
DELISTED
bluebird bio
BLUE
$2.14M 0.09%
3,809
– –
MRUS icon
109
Merus
MRUS
$5.04B
$2.11M 0.09%
+260,000
New +$2.11M
GBT
110
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.07M 0.08%
+125,000
New +$2.07M
KITE
111
DELISTED
Kite Pharma, Inc.
KITE
$2.05M 0.08%
41,000
– –
NTLA icon
112
Intellia Therapeutics
NTLA
$1.26B
$1.85M 0.08%
+86,842
New +$1.85M
ADYX
113
DELISTED
Adynxx, Inc. Common Stock
ADYX
$1.85M 0.08%
27,500
– –
QURE icon
114
uniQure
QURE
$954M
$1.78M 0.07%
241,021
– –
HALO icon
115
Halozyme
HALO
$8.75B
$1.73M 0.07%
200,000
– –
MNTA
116
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.66M 0.07%
153,700
– –
SLRX icon
117
Salarius Pharmaceuticals
SLRX
$2.45M
$1.66M 0.07%
2
-1
-33% -$828K
MACK
118
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.54M 0.06%
36,351
-36,083
-50% -$1.53M
FOLD icon
119
Amicus Therapeutics
FOLD
$2.42B
$1.41M 0.06%
258,000
– –
CDTX icon
120
Cidara Therapeutics
CDTX
$1.61B
$1.37M 0.06%
6,624
+2,999
+83% +$618K
RCKT icon
121
Rocket Pharmaceuticals
RCKT
$358M
$1.35M 0.05%
45,191
-76,657
-63% -$2.28M
CMRX
122
DELISTED
Chimerix, Inc.
CMRX
$1.21M 0.05%
308,892
– –
RVNC
123
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.02M 0.04%
75,000
+30,000
+67% +$408K
ESPR icon
124
Esperion Therapeutics
ESPR
$490M
$1.02M 0.04%
102,800
– –
TTPH
125
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$827K 0.03%
9,616
– –
2 3 4
5
6